CIK 0001553643
- Non-accelerated filer
- Smaller reporting company
RELMADA THERAPEUTICS, INC.
Sign in to watch- Ticker
- RLMD
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- Operating
- EIN
- 455401931
- Phone
- +1 646-876-3459
- Business address
- 2222 PONCE DE LEON BLVD. 3RD FLOOR, CORAL GABLES, FL, 33134
- Former names
- CAMP NINE, INC.
- Open-market buys, last 90 days
- $1,671,990
- in 2 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$1,671,990. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-02-11 | TRAVERSA SERGIO CEO | Sale | −1,446 | $35.43 | $51K | 88,774 |
| 2021-02-11 | TRAVERSA SERGIO CEO | Option exercise · Options to purchase common stock | −1,446 | 119,211 | ||
| 2021-02-11 | Shenouda Maged CFO | Option exercise | +1,428 | $3.24 | $5K | 3,656 |
| 2021-02-11 | Shenouda Maged CFO | Sale | −1,428 | $35.39 | $51K | 2,228 |
| 2021-02-11 | Shenouda Maged CFO | Option exercise · Options to purchase common stock | −1,428 | 83,250 | ||
| 2021-02-10 | TRAVERSA SERGIO CEO | Sale | −1,930 | $35.28 | $68K | 88,774 |
| 2021-02-10 | Shenouda Maged CFO | Sale | −2,410 | $35.20 | $85K | 2,228 |
| 2021-02-09 | TRAVERSA SERGIO CEO | Sale | −5,963 | $35.21 | $210K | 90,704 |
| 2021-02-09 | Kelly Paul Edward Director | Sale | −2,069 | $35.29 | $73K | 162,295 |
| 2021-02-09 | Shenouda Maged CFO | Sale | −5,359 | $35.24 | $189K | 4,638 |
| 2021-02-08 | Kelly Paul Edward Director | Option exercise · Options to purchase common stock | −5,000 | 55,500 | ||
| 2021-02-08 | TRAVERSA SERGIO CEO | Option exercise | +11,206 | $3.24 | $36K | 99,980 |
| 2021-02-08 | TRAVERSA SERGIO CEO | Sale | −3,313 | $35.03 | $116K | 96,667 |
| 2021-02-08 | TRAVERSA SERGIO CEO | Option exercise · Options to purchase common stock | −11,206 | 120,657 | ||
| 2021-02-08 | Kelly Paul Edward Director | Option exercise | +3,569 | $3.24 | $12K | 165,864 |
| 2021-02-08 | Kelly Paul Edward Director | Sale | −1,500 | $35.04 | $53K | 164,364 |
| 2021-02-08 | Kelly Paul Edward Director | Option exercise · Options to purchase common stock | −3,569 | 60,500 | ||
| 2021-02-08 | Shenouda Maged CFO | Option exercise | +11,372 | $3.24 | $37K | 13,600 |
| 2021-02-08 | Shenouda Maged CFO | Sale | −3,603 | $35.04 | $126K | 9,997 |
| 2021-02-08 | Shenouda Maged CFO | Option exercise · Options to purchase common stock | −11,372 | 84,678 |
Page 10 of 19 · 370 trades